Dipyridamole monotherapy in schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dipyridamole monotherapy in schizophrenia

Published:2011-05-03 Issue:2 Volume:218 Page:341-345
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Wonodi Ikwunga,Gopinath Hirekatur V.,Liu Judy,Adami Helene,Hong L. Elliot,Allen-Emerson Robert,McMahon Robert P.,Thaker Gunvant K.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-011-2315-3.pdf

Reference39 articles.

1. Akhondzadeh S et al (2000) Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions. J Clin Pharm Ther 25:131–137

2. Akhondzadeh S et al (2005) Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 29:253–259

3. Andreasen NC (1984) The scale for the assessment of positive symptoms (SAPS). University of Iowa, Iowa City

4. Boison D, et al. (2011) Adenosine hypothesis of schizophrenia — opportunities for pharmacotherapy. Neuropharmacology

5. Brunstein MG et al (2001) Therapeutic benefit of adjunctive dipyridamole in schizophrenia is probably due to adenosine–glutamate interactions. J Clin Pharm Ther 26:155–156

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel pharmacotherapy targeting the positive symptoms of schizophrenia;Expert Opinion on Pharmacotherapy;2023-07-10

2. The adenosine hypothesis of schizophrenia into its third decade: From neurochemical imbalance to early life etiological risks;Frontiers in Cellular Neuroscience;2023-03-14

3. Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?;International Journal of Molecular Sciences;2022-10-05

4. Repurposing Dipyridamole in Niemann Pick Type C Disease: A Proof of Concept Study;International Journal of Molecular Sciences;2022-03-22

5. Adenosine Receptors in Modulation of Central Nervous System Disorders;Current Pharmaceutical Design;2019-10-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3